What Crisis? Biopharma Rallies Strongly After COVID-19 Shock: New Report from Evaluate Vantage
“Pharma, Biotech and Medtech Half-Year Review 2020” analyses the market performance and deal landscape for the first half of 2020, focusing on the impact of COVID-19 LONDON & BOSTON…
